MIRANA THERAPEUTICS ApS: Financial statements 2017
CVR: 35208046
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
MIRANA THERAPEUTICS ApS (CVR 35208046) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -5,160 and a net result of DKK -4,041 compared with DKK -2,948 the year before. Equity in the 2017 report amounted to DKK 59,912. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -5,160
- Profit/Loss
- DKK -4,041
- Equity
- DKK 59,912
- Total Assets
- DKK 59,913
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 0 | -5K | -4K | 60K | - |
| 2016 | 112K | -4K | -3K | 64K | - |
| 2015 | 284K | -94 | -72 | 67K | - |
| 2014 | 29K | -4K | -3K | 67K | - |
Official annual report
Keep an eye on MIRANA THERAPEUTICS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
MIRANA THERAPEUTICS ApS has published its annual report for 2016. Revenue came to DKK 112,454, and the net result was DKK -2,948.
About MIRANA THERAPEUTICS ApS
MIRANA THERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in Birkerød, founded in 2013. The company has been dissolved on 3 July 2018. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK -5,160 and a net result of DKK -4,041 compared with DKK -2,948 the year before. Equity in the 2017 report amounted to DKK 59,912.